To assess whether the type of surgical approach to the sella (sublabial transseptal
vs transnasal) affects surgical outcome among patients with Cushing disease.
PARTICIPANTS AND METHODS
Both procedures were performed at our institution from January 1, 1995, through January
31, 2003. From a total of 106 patients with Cushing disease who had had surgery, we
identified 42 adults undergoing an initial surgery, with microadenoma (<1 cm) determined
by magnetic resonance imaging and a minimal follow-up of 3 months.
We identified 21 patients (4 male, 17 female) for sublabial transseptal transsphenoidal
microsurgery. Mean ± SD age was 45.0±12.9 years (range, 27.0-69.0 years); median duration
of symptoms was 2.5 years (range, 1.5-7.5 years). Median follow-up was 1.0 year (range,
0.3-11.0 years). We identified another 21 patients (5 male, 16 female) for endoscopic
transsphenoidal microsurgery whose mean ± SD age was 43.8±14.1 years (range, 19.0-70.0
years); median duration of symptoms was 2.4 years (range, 0.2-6.0 years). Median follow-up
was 2.5 years (range, 0.3-8.7 years). Complications (cerebrospinal fluid leak and
transient diabetes insipidus) and cure (86% initial cure; 76% relapse-included cure)
were equivalent between the 2 procedures. However, the endoscopic approach was associated
with shorter anesthesia time, less blood loss, and shorter hospital stays.
The endoscopic transnasal surgical approach led to shorter total anesthesia time,
less blood loss, and shorter hospital stay when compared with the sublabial transseptal
approach. However, we found no difference between the 2 surgical procedures with respect
to cure or complications, suggesting that outcome is more closely related to the experience
of the operating team.